Altamira Science & Technology
Globe 5-Star Rating
Fund Price: $7.43 (as at November 20, 2009) 1-day chg: $.02 0.27% YTD: 20.42%
Returns as at October 31, 2009
| Fund | Group Avg | Index* | |
|---|---|---|---|
| 1 Month | -1.10% | -2.70% | -3.18% |
| 3 Months | 3.30% | 3.50% | 3.21% |
| 6 Months | 3.30% | 12.34% | 7.46% |
| 1 Year | 6.35% | 16.94% | 5.25% |
| 2 Year Avg | -9.70% | -11.61% | -9.93% |
| 3 Year Avg | -3.57% | -3.54% | -6.05% |
| 5 Year Avg | -1.41% | 0.88% | -1.78% |
| 10 Year Avg | -9.84% | -7.19% | -6.61% |
| 15 Year Avg | - | 2.57% | 5.06% |
| 20 Year Avg | - | - | 7.33% |
| Since Inception | 3.44% | - | - |
| 2008 | -29.81% | -34.96% | -26.31% |
| 2007 | 4.39% | 3.87% | -6.89% |
| 2006 | 4.86% | 12.15% | 9.46% |
| 3 year risk | 18.27 | 20.93 | 19.27 |
| 3 year beta | 0.89 | 0.86 | 1.00 |
*NASDAQ Composite ($ Cdn)
Growth of $10,000
Risk Measures as at October 31, 2009
Best/Worst 12 months (since inception)
| Best (ending Feb 00): | 298.88 | ||
| Worst (ending Sep 01): | -77.02 | ||
Volatility meter (Based on 3 year standard deviation from Globefund.com)
LowFund Objectives
The fund's objective is to aggressively seek capital appreciation for investors over the long term (5+ years). To achieve its objectives, the fund will invest in global companies that exploit and develop scientific and technology research. The fund will endeavor to maximize returns by investing in a diversified portfolio of companies in the telecommunications, biotechnology, environment technology, healthcare and computer industries.
Fund Facts
| Fund Sponsor: | National Bank Mutual Funds |
| Managed by: | Altamira Management Ltd. |
| Fund Type: | MF Trust |
| Inception Date: | August 1995 |
| Asset Class: | Science and Technology Equity |
| Quartile Rank: | 3 (3YR ending October 31, 2009) |
| Total Assets: | $43.7 million |
| Mgmt Exp. Ratio (MER): | 2.35% |
| Management Fee: | 2.00% |
| Load Type: | No Load |
- Globe 5-Star Rating:
- RRSP Eligible:
- Canadian
- Min. Invest (initial):
- $1,000
- Subsequent:
- $50
- Min. Invest (initial RRSP):
- $1,000
- Subsequent RRSP:
- $50
- Closed:
- No
- Restricted:
- No
- Restriction:
Asset Allocation September 30, 2009
Equity Sector Weightings September 30, 2009
Fund Geography September 30, 2009
Top Holdings as at September 30, 2009
| Symbol | Company Name | Sector | Geographic Area |
Asset Type |
% of Total Assets |
Performance as at November 20, 2009 1 Year Performance (%) |
|||
|---|---|---|---|---|---|---|---|---|---|
| MSFT-Q | Microsoft | Computer Software & Processing | United States | Stock | 8.85 | 68.97 | |||
| GOOG-Q | Computer Software & Processing | United States | Stock | 6.93 | 119.59 | ||||
| AAPL-Q | Apple | Electrical & Electronic | United States | Stock | 6.16 | 148.38 | |||
| INTC-Q | Intel | Electrical & Electronic | United States | Stock | 6.14 | 57.32 | |||
| ORCL-Q | Oracle Corp. | Computer Software & Processing | United States | Stock | 4.88 | 45.06 | |||
| HPQ-N | Hewlett-Packard Co. | Electrical & Electronic | United States | Stock | 4.81 | 57.21 | |||
| IBM-N | IBM | Electrical & Electronic | United States | Stock | 4.49 | 76.97 | |||
| CSCO-Q | Cisco Systems | Electrical & Electronic | United States | Stock | 3.02 | 62.13 | |||
| SAP-N | SAP AG | Computer Software & Processing | Germany | Stock | 3.0 | 60.74 | |||
| QCOM-Q | Qualcomm | Telecommunications | United States | Stock | 2.82 | 54.4 | |||
| PFE-N | Pfizer | Biotechnology & Pharmaceuticals | United States | Stock | 2.53 | 27.06 | |||
| JNJ-N | Johnson & Johnson | Biotechnology & Pharmaceuticals | United States | Stock | 2.52 | 11.65 | |||
| - | Fanuc Limited | Machinery | Japan | Stock | 2.1 | - | |||
| MRK-N | Merck & Company | Biotechnology & Pharmaceuticals | United States | Stock | 2.0 | 54.75 | |||
Portfolio Manager(s)
Natcan Investment Mgmt. - Mgmt. Team
Natcan Investment Mgmt. Inc.
Start Date: August, 2002
Fund Return: -1.75%
Also manages:Altafund Investment Corp., Altamira Asia Pacific, Altamira Canadian Equity Growth, Altamira Canadian Index, Altamira Dividend, Altamira Energy Fund, Altamira European Equity, Altamira Global Bond, Altamira Global Small Co., Altamira Health Sciences, Altamira High Yield Bond, Altamira Income, Altamira International Index, Altamira Intl Currency Neutral Idx, Altamira Japanese Opportunity, Altamira Long Term Bond, Altamira Precious & Strategic Metal, Altamira Quebec Growth, Altamira Resource, Altamira Tactical Asset Allocation, Altamira US Currency Neutral Index, Altamira US Equity, Altamira US Index, Astra Aggressive Strategy, Astra Balanced Strategy, Astra Growth Strategy, FÉRIQUE Equity, IA Group Bonds (Natcan), IA Group Canadian Equity (Natcan), National Bank Balanced Diversified, National Bank Balanced Port, National Bank Balanced Strat. Port., National Bank Bond, National Bank Canadian Equity, National Bank Cdn Opportunities, National Bank Conser Strategic Port, National Bank Conservative Diversif, National Bank Corporate Cash Mgmt, National Bank Dividend, National Bank Equity Mngd Portfolio, National Bank Equity Strat Port NR, National Bank Global Equity, National Bank Growth Diversified, National Bank Growth Portfolio, National Bank Growth Strat Port NR, National Bank Inc & Grwth Mngd Port, National Bank Inc Managed Portfolio, National Bank Moderate Diversified, National Bank Moderate Strategic Po, National Bank Money Market, National Bank Monthly Conserv Inc, National Bank Monthly Equity Income, National Bank Monthly High Income, National Bank Monthly Income, National Bank Monthly Moderate Inc, National Bank Monthly Secure Income, National Bank Mortgage, National Bank Protected Cdn Bond, National Bank Protected Cdn Equ, National Bank Protected Global, National Bank Protected Gwth Bal, National Bank Protected Retr Bal, National Bank Secure Diversified, National Bank Secure Strategic Port, National Bank Short Term Cdn Income, National Bank Small Capitalization, National Bank Stable Inc Mngd Port, National Bank Strategic Yield Class, National Bank Treasury Management, National Bank U.S. Money Mkt (US$), Omega Global Opportunities
